Form 8-K - Current report:
SEC Accession No. 0001558370-21-011209
Filing Date
2021-08-11
Accepted
2021-08-11 06:03:32
Documents
13
Period of Report
2021-08-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rphm-20210811x8k.htm   iXBRL 8-K 40399
2 EX-99.1 rphm-20210811xex99d1.htm EX-99.1 223125
  Complete submission text file 0001558370-21-011209.txt   403845

Data Files

Seq Description Document Type Size
3 EX-101.SCH rphm-20210811.xsd EX-101.SCH 3033
4 EX-101.LAB rphm-20210811_lab.xml EX-101.LAB 16737
5 EX-101.PRE rphm-20210811_pre.xml EX-101.PRE 10611
6 EXTRACTED XBRL INSTANCE DOCUMENT rphm-20210811x8k_htm.xml XML 5056
Mailing Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612
Business Address 18575 JAMBOREE ROAD SUITE 275-S IRVINE CA 92612 (858) 283-0280
Reneo Pharmaceuticals, Inc. (Filer) CIK: 0001637715 (see all company filings)

EIN.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40315 | Film No.: 211161835
SIC: 2834 Pharmaceutical Preparations